Rubraca and Vertigo aggravated - a phase IV clinical study of FDA data

Summary:

We study 10,508 people who have side effects when taking Rubraca. Vertigo aggravated is found, especially among people who are female, 60+ old, have been taking the drug for < 1 month, also take Zofran and have Ovarian cancer.

The phase IV clinical study analyzes which people take Rubraca and have Vertigo aggravated. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 26, 2023

10,508 people reported to have side effects when taking Rubraca.
Among them, 601 people (5.72%) have Vertigo aggravated.

What is Rubraca?

Rubraca has active ingredients of rucaparib camsylate. Currently, eHealthMe is studying from 10,508 Rubraca users.

What is Vertigo aggravated?

Vertigo aggravated is found to be associated with 1,859 drugs and 637 conditions by eHealthMe. Currently, we are studying 130 people who have Vertigo aggravated.

Number of Rubraca and Vertigo aggravated reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Rubraca and have Vertigo aggravated?

Check whether Vertigo aggravated is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Rubraca side effects by duration, gender and age:

Rubraca side effects (10,508 reports)

Vertigo aggravated treatments and more:

Vertigo aggravated (130 reports)

Common drugs associated with Vertigo aggravated:

All the drugs that are associated with Vertigo aggravated:

Vertigo aggravated (1,859 drugs)

Common conditions associated with Vertigo aggravated:

All the conditions that are associated with Vertigo aggravated:

Vertigo aggravated (637 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rucaparib camsylate (the active ingredients of Rubraca) and Rubraca (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.